ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production

Growth Factors

Volumn 28, Issue 3, 2010, Pages 178-190

  Hacker, Christine ^a,b   Valchanova, Ralitsa ^a   Adams, Stephanie ^a   Munz, Barbara ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; SMALL INTERFERING RNA; TRISTETRAPROLIN; VASCULOTROPIN; ZINC FINGER PROTEIN;

ARTICLE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; KERATINOCYTE; MODULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; RNA INTERFERENCE; RNA STABILITY; SCRATCHING; SKIN INJURY; WOUND HEALING;

BUTYRATE RESPONSE FACTOR 1; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATINOCYTES; TRANSCRIPTION FACTORS; TRISTETRAPROLIN; VASCULAR ENDOTHELIAL GROWTH FACTORS; WOUND HEALING;

EID: 77952509603     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903578660     Document Type: Article

References (63)

1. Adams S, Pankow S, Werner S, Munz B. 2007. Regulation of NF-kB activity and keratinocyte differentiation by the RIP4 protein: Implications for cutaneous wound repair. J Invest Dermatol 127:538-544.
2. Amit I, Citri A, Shay T, Lu Y, Katz M, Zhang F, Tarcic G, Siwak D, Lahad J, Jacob-Hirsch J, Amariglio N, Vaisman N, Segal E, Rechavi G, Alon U, Mills GB, Domany E, Yarden Y. 2007. A module of negative feedback regulators defines growth factor signalling. Nat Genet 39:503-512.
3. Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS. 2001. ARED: Human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29:246-254.
4. Baou M, Jewell A, Muthurania A, Wickremasinghe RG, Yong KL, Carr R, Marsh P, Murphy JJ. 2009. Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. Leukemia 23:986-989.
5. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. 2008. Growth factors and cytokines in wound healing. Wound Repair Regen 16:585-601.
6. Batistatou A, Volonté C, Greene LA. 1992. Nerve growth factor employs multiple pathways to induce primary response genes in PC12 cells. Mol Biol Cell 3:363-371.
7. Beer HD, Fassler R, Werner S. 2000. Glucocorticoid-regulated gene expression during cutaneous wound repair. Vitam Horm 59:217-239.
8. Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, Burton GJ, Murphy JJ, Norton JD, Clark AR, Turner M. 2006. The RNA binding protein Zfp36l1 is required for normal vascularisation and post- transcriptionally regulates VEGF expression. Dev Dyn 235:3144-3155.
9. Birk DM, Barbato J, Mureebe L, Chaer RA. 2008. Current insights on the biology and clinical aspects of VEGF regulation. Vasc Endovasc Surg 42:517-530.
10. Blackshear PJ, Phillips RS, Ghosh S, Ramos SB, Richfield EK, Lai WS. 2005. Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins. Biol Reprod 73:1072.
11. Brennan SE, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, Wilson GM. 2009. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res 69:5168-5176.
12. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, Saklatvala J, Clark AR. 2006. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogenactivated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol 26:2408-2418.
13. Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van de Water L. 1995. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensivity skin reactions. J Immunol 154:2801-2807.
14. Busse M, Schwarzburger M, Berger F, Hacker C, Munz B. 2008. TIS11B is a regulator of myogenic differentiation. Eur J Cell Biol 87:163-172.
15. Cao H, Urban JF, Jr, Anderson RA. 2008. Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes. Obesity 16:1208-1218.
16. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. 1986. Identification of a common nucleotide sequence in the 3/-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83:1670-1674.
17. Carballo E, Lai WS, Blackshear PJ. 1998. Feedback inhibition of macrophage tumor necrosis factor alpha production by tristetraprolin. Science 281:1001-1005.
18. Carballo E, Lai WS, Blackshear PJ. 2000. Evidence that tristetraprolin is a physiological regulator of granulocytemacrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95:1891-1899.
19. Carballo E, Cao H, Lai WS, Kennington EA, Campbell D, Blackshear PJ. 2001. Decreased sensitivity of tristetraprolindeficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J Biol Chem 276:42580-42587.
20. Carrick DM, Blackshear PJ. 2007. Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines. Arch Biochem Biophys 462:278-285.
21. Ciais D, Cherradi N, Bailly S, renier E, Berra E, Pouyssegur J, Lamarre J, Feige JJ. 2004. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 23:8673-8680. (Pubitemid 39576474)
22. Cooper P, Potter S, Mueck B, Yousefi S, Jarai G. 2001. Identification of genes induced by inflammatory cytokines in airway epithelium. A J Physiol Lung Cell Mol Physiol 280:841-852.
23. Corps AN, Brown KD. 1995. Insulin and insulin-like growth factor I stimulate expression of the primary response gene cMG1/Tis11b by a wortmannin-sensitive pathway in RIE-1 cells. FEBS Lett 368:160-164.
24. Cuenda A, Cohen P, Buée-Scherrer V, Goedert M. 1997. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 16:295-305.
25. Dayem MA, Moreilhon C, Turchi L, Magnone V, Christen R, Ponzio G, Barbry P. 2003. Early gene expression in wounded human keratinocytes revealed by DNA microarray analysis. Comp Funct Genomics 4:47-55.
26. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF. 1994. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-1146.
27. DuBois RN, Bishop PR, Graves-Deal R, Coffey RJ. 1995. Transforming growth factor alpha regulation of two zinc finger-containing immediate early response genes in intestine. Cell Growth Differ 6:523-529.
28. Efimova T, Broome AM, Eckert RL. 2003. A regulatory role for p38 delta in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation. J Biol Chem 278:34277-34285.
29. Emmons J, Townley-Tilson WH, Deleault KM, Skinner SJ, Gross RH, Whitfield ML, Brooks SA. 2008. Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA 14:888-902.
30. Fechir M, Linker K, Pautz A, Hubrich T, Fõrstermann U, Rodriguez-Pascual F, Kleinert H. 2005. Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Mol Pharmacol 67:2148-2161.
31. Fitsialos G, Chassot AA, Turchi L, Dayem MA, LeBrigand K, Moreilhon C, Meneguzzi G, Buscá R, Mari B, Barbry P, Ponzio G. 2007. Transcriptional signature of epidermal keratinocytes subjected to in vitro scratch wounding reveals selective roles for ERK1/2, p38, and phosphatidylinositol 3-kinase signaling pathways. J Biol Chem 282:15090-15102.
32. Frank S, Hũbner G, Breier G, Longaker MT, Greenalgh DG, Werner S. 1995. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270:12607-12613.
33. Frank S, Kãmpfer H, Wetzler C, Pfeilschifter J. 2002. Nitric oxide drives skin repair: Novel functions of an established mediator. Kidney Int 61:882-888.
34. Garcia-Gras EA, Chi P, Thompson EA. 2000. Glucocorticoidmediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3/-untranslated region of the mRNA. J Biol Chem 275:422001-22008.
35. Gille J, Reisinger K, Westphal-Varghese B, Kaufmann R. 2001. Decreased mRNA stability as a mechanism of glucocorticoid mediated inhibition of vascular endocthelial growth factor gene expression by cultured keratinocytes. J Invest Dermatol 117:1581-1587.
36. Gomperts M, Pascall JC, Brown KD. 1990. The nucleotide sequence of a cDNA encoding an EGF-inducible gene indicates the existence of a new family of mitogen-induced genes. Oncogene 5:1081-1083.
37. Gomperts M, Corps AN, Pascall JC, Brown KD. 1992. Mitogeninduced expression of the primary response gene cMG1 in a rat intestinal epithelial cell line (RIE-1). FEBS Lett 306:1-4.
38. Gurtner GC, Werner S, Barrandon Y, Longaker MT. 2008. Wound repair and regeneration. Nature 453:314-321.
39. Hashimoto K. 2000. Regulation of keratinocyte function by growth factors. J Dermatol Sci 24:46-50.
40. Horner TJ, Lai WS, Stumpo DJ, Blackshear PJ. 2009. Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin. Mol Cell Biol 29:1999-2010.
41. Ishmael FT, Fang X, Galdiero MR, Atasoy U, Rigby WF, Gorospe M, Cheadle C, Stellato C. 2008. Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation. J Immunol 180:8342-8353.
42. Jalonen U, Lahti A, Korhonen R, Kankaanranta H, Moilanen E. 2005. Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. Biochem Pharmacol 69:733-740.
43. Johnson BA, Geha M, Blackwell TK. 2000. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Oncogene 19:1657-1664.
44. Johnson BA, Blackwell TK. 2002. Multiple tristetraprolin sequence domains required to induce apoptosis and modulate responses to TNFalpha through distinct pathways. Oncogene 21:4237-4246.
45. Kaneda N, Oshima M, Chung SY, Guroff G. 1992. Sequence of rat TIS11 cDNA, an immediate early gene induced by growth factors and phorbol esters. Gene 118:289-291.
46. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. 1997. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235:533-538.
47. Lai WS, Stumpo DJ, Blackshear PJ. 1990. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem 265:16556-16563.
48. Lai WS, Carballo E, Thorn JM, Kennington EA, Blackshear PJ. 2000. Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. J Biol Chem 275:17827-17837.
49. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ. 2006. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol 26:9196-9208.
50. Ma Q, Herschman HR. 1995. The yeast homologue YTIS11, of the mammalian TIS11 gene family is a non-essential, glucose repressible gene. Oncogene 10:487-494.
51. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21:6461-6469.
52. Man XY, Yang XH, Cai SQ, Yao YG, Zheng M. 2006. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol Med 12:127-136.
53. Man XY, Yang XH, Cai SQ, Bu ZY, Zheng M. 2008. Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: Regulated by calcium independent of VEGF. J Cell Mol Med 12:649-660.
54. Man XY, Yang XH, Cai SQ, Bu ZY, Wu XJ, Lu ZF, Zheng M. 2009. Expression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: A comparison study by immunofluorescence. Clin Exp Dermatol 34:396-401.
55. Manabe T, Fukuda K, Pan J, Nagasaki K, Yamaguchi K, Ogawa S. 1999. Hypertrophic stimuli augment expression of cMG1/ERF-1, a putative zinc-finger motif transcription factor, in rat cardiomyocytes. FEBS Lett 463:39-42.
56. Varnum BC, Lim RW, Sukhatme VP, Herschman HR. 1989a. Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene 4:119-120.
57. Varnum BC, Lim RW, Kujubu DA, Luner SJ, Kaufman SE, Greenberger JS, Gasson JC, Herschman HR. 1989b. Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary response TIS genes in both proliferating and terminally differentiated myeloid cells. Mol Cell Biol 9:3580-3583.
58. Varnum BC, Ma QF, Chi TH, Fletcher B, Herschman HR. 1991. The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual CysHis repeat. Mol Cell Biol 11:1754-1758.
59. Werner S, Breeden M, Hübner G, Greenhalgh DG, Longaker MT. 1994. Induction of keratinocyte growth factor expression is reduced and delayed in the genetically diabetic mouse. J Invest Dermatol 103:469-473.
60. Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R, DiPietro LA. 2005. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 167:1257-1266.
61. Yang XH, Man XY, Cai SQ, Yao YG, Bu ZY, Zheng M. 2006. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects. Biochem Biophys Res Commun 349:31-38.
62. Yin T, Yang YC. 1993. Protein tyrosine phosphorylation and activation of primary response genes by interleukin 11 in B9-TY1 cells. Cell Growth Differ 4:603-609.
63. Yoo PS, Mulkeen AL, Cha CH. 2006. Post-transcriptional regulation of vascular endothelial growth factor: Implications for tumor angiogenesis. World J Gastroenterol 12:4937-4942.